H2U Health Receives Investment from Yonglin, Fwusow; to List on TPEx Growth Board End of July

(CNA Reporter Ho Hsiu-ling Taipei, June 29) Digital health technology platform H2U Health, with health data, AI, and preventive medicine at its core, is expected to list on the TPEx Growth Board by the end of July this year. Chairman Chen Chun-chia stated that while health media advertising currently accounts for the largest portion of revenue, with the health information platform transitioning to a SaaS subscription model, it is anticipated to surpass media advertising in the future, aiming for quarterly profits starting in the fourth quarter of next year and to turn profitable annually the year after.

H2U Health held a media exchange event today. Chen Chun-chia said that H2U Health was founded in 2013, initially to provide health care for Foxconn's global employees. Its operational model primarily involves serving health examination institutions and corporate clients to establish health data entry points. By integrating digital content and interactive scenarios accumulated through the health media "Health Times" and the sports community "Running Biji," it forms a service ecosystem spanning health content, health data, and health actions, covering business-to-business (B2B), business-to-business-to-consumer (B2B2C), and business-to-consumer (B2C) businesses.

H2U Health's largest shareholder is Jialun Biotechnology, under the Yonglin Foundation founded by Foxconn founder Terry Gou. The second-largest shareholder is Fwusow Food Industrial.

Chen Chun-chia stated that based on current revenue breakdown, within H2U Health's core business, "health media advertising," which transmits health information through professional platforms to help brands reach target audiences, accounts for 32%. "Health information platforms" that provide employer health management platforms and health examination management platforms, and "sports event operations" each account for 19%. Health product sales and e-commerce agency operations account for 17%, and public sector projects account for 13%.

According to H2U Health's prospectus, revenue for the first three quarters of 2025 was NT$305 million, with a loss attributable to parent company owners of NT$139 million, and a loss per share of NT$3.34.

Chen Chun-chia said that the largest revenue share currently comes from health media advertising. However, as the health information platform transitions to a Software as a Service (SaaS) subscription model, meaning the transformation of one-time system construction revenue into monthly fees or annual contracts to establish stable cash flow, platform revenue is expected to approach media advertising revenue starting in 2027 and exceed media advertising revenue in 2028.

Furthermore, H2U Health has gradually reduced the operations of its subsidiaries in mainland China and Hong Kong in recent years, and has terminated e-commerce related businesses to reduce losses. H2U Health stated that it hopes to achieve quarterly profits in the fourth quarter of next year and to achieve full-year profitability the year after.

Chen Chun-chia also mentioned that the second-largest shareholder, Fwusow, invested in H2U Health because it values the ability to better understand product sales targets and health improvement status through health data and member ecosystems. In the future, H2U will become a new type of channel for Fwusow. Collaborations already cover health education, sports events, and member marketing, and related cooperation is expected to continue driving revenue growth. (Editor: Yang Kai-hsiang) 1150629

Stand with facts, your every donation is a force to protect the freedom of the press.

Download the CNA "One News" APP to grasp the latest news in real-time.

Text, images, and videos on this website may not be reproduced, publicly broadcast, publicly transmitted, or used without authorization.